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ABSTRACT
MicroRNAs (miRNAs) are short non-coding RNAs
that regulate gene output at the post-transcriptional
level by targeting degenerate elements primarily in
3′untranslated regions (3′UTRs) of mRNAs. Individ-
ual miRNAs can regulate networks of hundreds of
genes, yet for the majority of miRNAs few, if any, tar-
gets are known. Misexpression of miRNAs is also
a major contributor to cancer progression, thus
there is a critical need to validate miRNA targets
in high-throughput to understand miRNAs’ contri-
bution to tumorigenesis. Here we introduce a novel
high-throughput assay to detect miRNA targets in
3′UTRs, called Luminescent Identification of Func-
tional Elements in 3′UTRs (3′LIFE). We demonstrate
the feasibility of 3′LIFE using a data set of 275 hu-
man 3′UTRs and two cancer-relevant miRNAs, let-
7c and miR-10b, and compare our results to alter-
native methods to detect miRNA targets throughout
the genome. We identify a large number of novel gene
targets for these miRNAs, with only 32% of hits being
bioinformatically predicted and 27% directed by non-
canonical interactions. Functional analysis of target
genes reveals consistent roles for each miRNA as ei-
ther a tumor suppressor (let-7c) or oncogenic miRNA
(miR-10b), and preferentially target multiple genes
within regulatory networks, suggesting 3′LIFE is a
rapid and sensitive method to detect miRNA targets
in high-throughput.
INTRODUCTION
MicroRNAs (miRNAs) are short non-coding RNAs that
bind to sequence elements primarily in the 3′untranslated
regions (3′UTRs) of messenger RNAs (mRNAs), result-
ing in mRNA degradation or translational repression (1).
MiRNAs are expressed in nearly every eukaryotic cell type
investigated to date, where they regulate fundamental bi-
ological processes such as development and morphogene-
sis (2). Furthermore, miRNA misregulation has also been
observed in a wide range of cancers (3), where they can
function as tumor suppressors or oncogenic miRNAs (on-
comiRs) (4), based solely on the function of target genes.
The misexpression of miRNAs can have substantial conse-
quences in development and disease, highlighting the pow-
erful role miRNAs play in influencing cell behavior. In hu-
man, each miRNA is predicted to target hundreds to thou-
sands of genes based on complementarity with mRNAs (5),
thus identifying and experimentally validating gene targets
is central to understanding an miRNA function. To ana-
lyze the large number of putative miRNA/mRNA inter-
actions, bioinformatic and next-gen sequencing approaches
are commonly used to predict and identify miRNA target
sites throughout the genome. Each approach has inherent
strengths and shortfalls.
Many algorithms have been developed to predict miRNA
target sites throughout the transcriptome by searching for
regions of complementarity withmRNAs byWatson–Crick
and G:U wobble base pairing (1). These interactions may
utilize as little as six consecutive nucleotides near the 5′end,
or seed region, of thematuremiRNA (5–7). Perfect comple-
mentarity with the seed region is considered the canonical
indicator of an miRNA target site, but can be strengthened
by additional pairing with the 3′end of the miRNA. Due
to the small size and degenerate nature of target sequence
elements, most algorithms predict hundreds to thousands
of putative target genes for each miRNA. These algorithms
typically apply parameters such as stringent seed pairing,
cross-species conservation and thermodynamic stability to
identify high-confidence targets (5,8). However, the anal-
ysis of the predictive performance of several of the most
prominent algorithms reports extremely high false-negative
(9–11) (Supplementary Figure S1) and false-positive rates
(∼66%) (12,13). These error rates reflect that these algo-
rithms typically do not predict poorly conserved species-
specific interactions or non-canonical targets not reliant on
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perfect seed complementarity, which recent evidence sug-
gests may be widespread (11–12,14–20). These algorithms
are useful for candidate gene approaches to identify puta-
tive miRNA targets, but the high error rates make system-
atic target detection challenging.
Several recently developed techniques allow the exper-
imental detection of miRNA targets on a transcriptome
wide level, bypassing target prediction software. One of the
most used methods combines the cross-link and immuno-
precipitation of argonaute (AGO) family members with
next-generation sequencing (AGO-HITS-CLIP). AGOpro-
teins directly bind mature miRNAs and guide the large
multi-protein complex called the RNA-induced silencing
complex (RISC) to target mRNAs. By sequencing the
mRNA population bound to AGO, it is possible to map the
sequence footprints occupied by the RISC on specific genes
(21). However, the physical immunoprecipitation of AGO
from cell lysates is often challenging to execute and may
add unwanted noise, impacting reproducibility and com-
plicating downstream analysis. Importantly, while this ap-
proach produces hundreds to thousands of targets, it does
not provide information about which miRNA led the RISC
to that location, which has to be extracted using bioin-
formatic approaches (22). Furthermore, AGO-HITS-CLIP
fails to measure the functional impact of miRNA targeting
on the level of protein synthesis. The result of targeting by
theRISC can range from translational repression tomRNA
degradation (13), and it is not currently clear if these alter-
native mechanisms bias the results of AGO-HITS-CLIP to-
ward target sites that are held in translational repression.
While AGO-HITS-CLIP is an excellent method to detect
miRNA target sites in high-throughput in a specific biolog-
ical context, the limitations with assigning an miRNA and
the lack of a functional measure of targeting limit this ap-
proach.
To address these gaps, we have developed a high-
throughput assay to probe for interactions between miR-
NAs and their targets in 3′UTRs. This assay, named Lumi-
nescent Identification of Functional Elements in 3′UTRs
(3′LIFE), is capable of measuring direct interactions be-
tween a test 3′UTR and a query miRNA using a dual lu-
ciferase approach. Luciferase assays rely on the fusion of
the 3′UTR of a gene of interest to a luciferase reporter
gene. The reporter is cotransfected with a query miRNA in
cell culture. Targeting is measured as a relative change be-
tween the test 3′UTR reporter and a second, non-targeted
luciferase reporter. Luciferase assays offer several advan-
tages over other methods to identify miRNA targets such as
mRNA sequencing and protein quantification approaches.
Quantification of the luciferase assay occurs at the protein
level, but reflects interactions at the RNA level between
the miRNA and 3’UTR, bypassing differences in mRNA
degradation/translational repression, and changes in pro-
tein abundance independent of 3’UTR based regulation.
Luciferase assays are sensitive and scalable, yet use in high-
throughput screens is greatly limited by (i) high costs associ-
ated with consumable reagents, (ii) lack of publically avail-
able 3′UTR reporter libraries and (iii) the absence of stan-
dardized dual luciferase protocols to perform large-scale
screens, leading to difficulties in comparing functional re-
pression across multiple data sets.
The 3′LIFE assay enhances the dual luciferase assay by
placing emphasis on the rapid, sensitive, standardized and
high-throughput screening for miRNA targets. These ad-
vances include the development of a test 3′UTR library,
GatewayTM compatible miRNA expression and 3′UTR re-
porter plasmids, non-consumable transfection reagents and
non-commercial dual-luciferase assay reagents (23). Impor-
tantly, the scalability of the 3′LIFE assay allows screens
of individual miRNAs against a large 3′UTR library with-
out biasing the screen toward candidate genes identified
bioinformatically (24), allowing the identification of genes
targeted via non-canonical and poorly conserved interac-
tions. Importantly, the sensitivity of the luciferase reporters
combined with the inherently large number of negative
miRNA/mRNA interactions in 3′LIFE allows for detec-
tion of the subtle effects of miRNA targeting, a benefit not
possible with low throughput, candidate gene or other se-
lection based reporter assays (25).
To test the ability of the 3′LIFE assay to detect biologi-
cally relevant target genes, we studied the targets of two can-
cer relevant miRNAs, let-7c and miR-10b. The let-7 family
members are broadly characterized as tumor suppressors;
reduction in the expression of multiple family members is
observed in many cancers and correlates with poor survival
outcomes (26–29). let-7miRNAs target genes that promote
cell proliferation [RAS (30), HMGA2 (26), E2F5 (31,32)]
and invasion and metastasis [MMP11, PBX3 (33)]. Each
let-7 miRNA is bioinformatically predicted to target over
1000 genes (5), with overlapping target sets. miR-10b was
initially described in the context of late-stage breast can-
cer, where overexpression initiated malignancy in vivo (34).
Subsequently,miR-10b overexpression has been observed in
over a dozen late-stage tumor types (35–38). There are sev-
eral validated targets of miR-10b including tumor suppres-
sors HOXD10, KLF4 and NCOR2 (34,39–41). Despite the
significant body of research (283 publications in PubMed)
on these miRNAs, it is striking that the number of targets
with direct experimental validation equates to less than 3%
of bioinformatically predicted targets (5,40).
We tested the feasibility of the 3′LIFE assay by query-
ing let-7c and miR-10b against 275 test human 3′UTRs.
Our results confirmed 80% of previously validated targets
and identified many novel targets for these two miRNAs.
In comparing the 3′LIFE assay to TargetScan, a widely
utilized target prediction software, we identify that 63%
of predicted targets have some degree of repression in the
3′LIFE screen, yet 69% of top targets were not predicted,
and ∼27% did not contain a canonical seed target. We also
observed that many miRNA target genes contain unpre-
dicted canonical seed elements and demonstrate this is likely
due to poor conservation within 3′UTRs of unpredicted
genes, and not at miRNA target sites per se. Taken together,
our results suggest that the 3′LIFE assay is a powerful tool
to rapidly and systematically identify miRNA targets in
high-throughput, validate bioinformatic predictions, iden-
tify novel non-canonical targets and highlights the complex-
ity of miRNA targeting mechanisms.
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MATERIALS AND METHODS
MiRNA target analysis of target prediction software
We have extracted the predicted targets and their prediction
scores for the miRNAs let-7c,miR-10b,miR-125a,miR-138
andmiR-22 from the TargetScan (5), PicTar (8) and Diana-
microT (42) websites. For TargetScan, the default conser-
vation filter was used, although we include both ‘Conserved
sites’ and ‘Poorly conserved sites’ in our analysis. The target
score for each gene was normalized using the mean target
score per miRNA. A list of the validated targets was com-
piled using Tarbase (43), miRTarBase (40) and a manual
literature search using the gene name and all aliases listed
in NCBI gene database. A gene was assigned as a validated
target if it had at least two distinct experimental methods
demonstrating direct miRNA regulation.
pLIFE-3′UTR vector construction
The original luciferase vector T7 DLP was kindly provided
by Dr John Chaput. The SV40 3′UTR was amplified from
the pcDNA3.1/V5-his vector and introduced downstream
of the Renilla luciferase open reading frame by introduc-
ing the restriction sites for NsiI and XmaJI (Supplemen-
tary Figure S2A). The internal ribosome entry site (IRES)
was replaced with the phosphoglycerate kinase 1 (PGK)
promoter by introducing a PstI restriction site and ligated
using BamHI and PstI restriction sites upstream of fire-
fly luciferase. The P2R-P3 Gateway cassette was amplified
from the pDONR P2R-P3 (Invitrogen) and cloned down-
stream of firefly luciferase gene by introducing BglII and
NheI restriction sites using QuikChange site-directed mu-
tagenesis (Agilent). MS2 repeats were amplified from pSL-
MS2–6x (AddGene Clone ID: 27118). Four MS2 repeats
were cloned downstream of firefly luciferase using BglII and
ApaI restriction sites for use in downstream RNA isola-
tion protocols. This vector is available through DNASU
(http://dnasu.org Clone ID EvNO00601503) (44).
pLIFE-miRNA vector construction
The miRNA expression vector (pLIFE-miRNA) was
adapted from the pCAG-RFP-miRint plasmid (45). We re-
placed the cytomegalovirus early enhancer/chicken beta
actin (CAG) promoter with the cytomegalovirus (CMV)
promoter by introducing SpeI and SacI restriction sites
upstream of the DSRed2 open reading frame using
QuikChange site-directed mutagenesis (Agilent). let-7c and
miR-10b were amplified from human genomic DNA and
cloned into the pLIFE-miR vector using the AsiSI and
NotI restriction sites. We included ∼200 nucleotides up-
stream and downstream from the surrounding genomic lo-
cus to replicate endogenous miRNA processing. We also
created a Gateway compatible miRNA expression plas-
mid, which contains the L2R3 Gateway cassette cloned
into AsiSI and MluI restriction sites (Supplementary Fig-
ure S2B). This vector is available through DNASU (http:
//dnasu.org, Clone IDEvNO00601504) (44). To prepare the
pLIFE-PGK miRNA expression vector, which produces
low expression level for the test miRNAs, we amplified the
PGK promoter from the pLIFE-3′UTR plasmid and lig-
ated it into the pLIFE-miRNA plasmid using SpeI and
XhoI restriction sites.
Test 3′UTR library preparation
We designed primers to amplify 384 3′UTRs from var-
ious protein-coding genes based on the RefSeq annota-
tion (HG19) and custom Perl scripts (46). Forward primers
were anchored to the 3′end of the terminal exon. Reverse
primers anchor ∼150 nucleotides beyond the end of the
longest annotated 3′UTR to include putative elements im-
portant for mRNA processing (47). The attB2 and attB3
Gateway cloning elements were added to the ends for the
forward and reverse primers, respectively. Primers were ar-
rayed based on annealing temperature and expected ampli-
con size (Supplementary Table S1). Genomic DNAwas iso-
lated from HEK293T cells using DNAzol (Invitrogen), per
manufacturer’s protocol. Touchdown-polymerase chain re-
action (PCR) was conducted using Taq polymerase (Invit-
rogen) in 96-well plates with 100-ng genomicDNAper PCR
reaction. Cycling conditions were based on manufacturers
protocol, with the addition of∼15 touchdown cycles, where
the annealing temperature started at 14◦C above the low-
est primer Tm on each plate, decreasing 1◦C per cycle for
15 cycles. Remaining cycles were carried out at 55◦. Ampli-
cons were then recombined into the pLIFE-3′UTR vector
using BP Clonase reactions (Invitrogen) per manufacturer’s
protocol. Cloning reactions were incubated overnight at
room temperature, and 1 l of the cloning reaction was
transformed into DH5- bacteria cells and plated on 48-
well LB-amp agar plates. We initially picked one colony per
well, and individual colonies were screened for correct size
using universal primers that flank the P2R-P3 cassette in
colony PCR experiments. Twenty percent were randomly
picked and sequence verified. Clones that passed these tests
were further used in the 3′LIFE assay. In our positive
and negative control experiments, we recombined the SV40
3′UTR into the pLIFE-3′UTR vector using BP Clonase
(Invitrogen), and introducing control miRNA targets for
let-7c (AACCATACAACCTACTACCTCA) and miR-10b
(ACAAATTCGGTTCTACAGGGTA) using QuikChange
site-directed mutagenesis (Agilent). Putative miRNA seeds
in RhoB and HOXD11 were deleted from the 3′UTR lu-
ciferase reporter plasmids using QuikChange site-directed
mutagenesis.
Plasmid DNA preparation
pLIFE-miRNA plasmids were prepared using Maxi Preps
(Promega) and the recovered DNA was resuspended to a
concentration of 500 ng/l. Bacterial stocks of pLIFE-
3′UTR plasmids were arrayed in 96-well 2-ml blocks and
grown for ∼16 h in 1.3-ml of Terrific Broth. Plasmids
were purified using the Nucleospin 96-well mini-prep kit
(Macherey-Nagel) and the Biomek FX (Beckman Coulter)
liquid handling robot according to manufacturers’ proto-
col. DNA was eluted in 50 l of nuclease-free water. DNA
concentrations were then normalized to ∼100 ng/l using
the Biomek FX liquid handling robot. To facilitate the as-
say in high-throughput, we have also optimized this step us-
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ing in-house HighRes Biosolutions fully automated DNA
miniprep systems that include three Liconic automated
800RPM/37C incubators, one automated Liconic auto-
mated −20◦C freezer, three Denso fully articulated robotic
arms, two Heraeus robotic centrifuges, two Thermo Well-
mate bulk dispensers, one Thermo combi bulk dispenser,
two KBio Wasp automated plate sealers, one Nexus auto-
mated plate pealer, one Molecular Devices DTX880 Plate
Reader, one Beckman Biomek FX dual arm 96/SPAN 8
liquid Handler, one EL405 plate washer and two ambient
automated plate storage hotels.
Cell culture
HEK293T cells were kindly provided by Dr Josh LaBaer.
Cells were cultured in Dulbecco’s modified Eagle’s medium
(Sigma), supplemented with 10% fetal bovine serum
(Fisher) and 1% penicillin/streptomycin (Fisher).
Nucleofection buffer test
A significant cost associated with high-throughput cell-
based assays is consumable reagents associated with trans-
fection, thus we tested a panel of buffers for efficient trans-
fection and cell survival using the 96-well Shuttle De-
vice by Lonza. An initial panel of 11 buffers and the SF
cell line solution (Lonza) were used to transfect 1 × 105
HEK293T cells with 100-ng pmaxGFP plasmid (Lonza).
Each buffer was tested using several different nucleofec-
tion pulse codes. As the conditions of these pulse codes
are proprietary, exact pulse conditions are unknown. The
pulse codes tested were ER100, CU123, CM102, EO115,
DT130, FF120, CN114, CM130, CB150, DS150, CA123
and DS138. We tested the following buffer solutions: phos-
phate buffered saline (PBS) (pH 7.4), PBS + 10% HEPES
(pH 7.0), PBS + 10% HEPES (pH 7.4), PBS + 5% HEPES
(pH 7.0), PBS + 1.5% HEPES (pH 7.0), HEPES buffered
saline (HBS), 50% PBS/50%HBS, BD PermWash, electro-
poration buffer and phosphate buffered sucrose. HBS so-
lution contains 140-mMNaCl + 1.5-mMNa2HPO4•2H2O
+ 50-mM HEPES. Electroporation buffer contains 15-mM
potassium phosphate + 1-mMMgCl2 + 250-mM sucrose +
10-mMHEPES adjusted to pH 7.3 using concentratedHCl.
Phosphate buffered sucrose solution contains 272-mM su-
crose + 7-mM K2HPO4 and is pH adjusted to 7.4 with
phosphoric acid. HBS and PBS HEPES consistently pro-
duced high transfection efficiency and/or cell survival, so
we performed secondary experiments using permutations
of pH and buffer composition: 75% PBS/25% HBS, 50%
PBS/50% HBS, 25% PBS/75% HBS, PBS 1% HEPES (pH
7.0), PBS 1.5% HEPES (pH 7.0), PBS 1.5% HEPES (pH
6.4), PBS 1.5% HEPES (pH 7.4) and PBS 2% HEPES (pH
7.0). Because PBS 1.5% HEPES (pH 7.0) in combination
with the FF120 pulse code yielded relatively few nucleofec-
tion errors, had high transfection efficiency, and relatively
high cell survival with HEK293T cells, this protocol was
used for all subsequent experiments.
Nucleofection protocol
A detailed 3′LIFE protocol is included in the Supplemen-
tary Materials and Methods and updates are available at
www.mangonelab.com. In brief, cells were grown to ∼90%
confluency and passaged between 24 and 48 h prior to trans-
fection to be in logarithmic growth phase at the time of
transfection. Cells were removed from a 145-mmparent cul-
ture plate with 0.25% trypsin (Fisher) for 3 min, washed
with an equal volume of media and spun for 5 min at 300 g.
Media/trypsin was eluted and cell pellet was resuspended
to a density of ∼3.0 × 107 cells/ml. For each well, 100 000
cells were pelleted and resuspended in 20l of nucleofection
buffer/plasmid solution, in the presence of no more than
2 l of plasmid DNA (10% total volume). Each well con-
tained a plasmid solution composed of 500 ng of pLIFE-
miRNA and 100 ng of pLIFE-3′UTR. Cell/buffer solution
was loaded into a 96-well shuttle plate and transfected via
nucleofection using the 96-well Shuttle System according
to manufacturer’s conditions (Lonza). Immediately follow-
ing nucleofection, 80l of pre-warmed complete media was
added into eachwell. Transfected cells were then transferred
to a 96-well culture plate to a total volume of 200-l media.
Each plate containing human 3′UTRs cloned into pLIFE-
3′UTR vector was transfected in quadruplicate, with each
replicate co-transfected with either the empty miRNA vec-
tor control, pLIFE-miR let-7c ormiR-10b. Transfected cells
were incubated for 48–72 h post transfection to minimize
non-specific effects caused by cascades of changing gene ex-
pression due to exogenous miRNAs. Cell are then imaged
using fluorescence microscopy and dsRed2 protein to iden-
tify wells with failed transfections, and subjected to the lu-
ciferase assay.
Luciferase assay
Prior to luciferase assay, the media was removed and cells
were lysed for 30 min in the presence of 26 l of pas-
sive lysis buffer (Promega) and gentle rocking. 25 l of to-
tal lysate was removed from the culture plate and trans-
ferred to opaque white 96-well plates and used in the lumi-
nescence assay. The non-commercial dual-luciferase buffer
was prepared as previously described (23). Coelenterazine
(Promega) was resuspended in 5-mM acidified methanol
and stored at −80◦C. Beetle luciferin (Promega) was re-
suspended in nuclease-free water and stored at −80◦C. In-
dividual buffer components were prepared and stored at
10X concentration. Buffers were prepared fresh with stored
reagents prior to each luciferase assay. Luminescence was
measured using the Glomax 96 Microplate Luminometer
with dual injectors (Promega). 100-l of firefly luciferase
and Renilla buffers were injected sequentially, followed by
a 5-s delay and a 10-s measurement time.
Statistical analysis of luciferase assay
Raw data from firefly and Renilla luciferase luminescence
assay were recorded for each well. We calculated the ratio
between firefly and Renilla using the relative light units ob-
tained for eachwell, to control variation inDNAconcentra-
tions, cell number and transfection efficiency. The ratio of
the firefly andRenilla luciferase values between the negative
miRNA control and its correspondent miRNA experiment
was then used to calculate the absolute repression (A) for
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each well using the following formula (1):
Absolute repression (A) = FLucwell/RLucwell
FLucblank/RLuccblank
. (1)
The normalized repression value (N) was obtained by av-
eraging the repression of every well across a plate and used
to normalize each well (2):
Normalized repression (N) = Awell
X¯ (Awell A1,A2...H12)
. (2)
This transformation measures repression as a function of
all the 3′UTRs on each plate and allows the comparison of
replicates of the experiment, removing fluctuations in raw
FLuc/Ren ratios caused by subtle variation in the luciferase
buffers and luminometers. Each plate is performed in qua-
druplicate on different days, and normalized repression ra-
tios for each well are averaged to obtain miRNA repression
index (RI) (3):
miRNA repression index (RI) = X¯ (NReplicate 1,2,3,4). (3)
We then rank the results based on the RI value, and pu-
tative hits are defined as 3′UTRs with an RI <0.80, and
obtain a statistically significant repression (P < 0.05) using
student’s t-test.
pLIFE-PGK secondary screen
To quantify PGK expression levels, pmiRNA-LIFE
or pmiRNA-LIFE-PGK was cotransfected with the
pmaxGFP plasmid (Lonza). Fluorescent images for RFP
and GFP were obtained, and expression levels were calcu-
lated using ImageJ (NIH) with standard parameters. To
test the effect of miRNA overexpression on positive hits,
one plate containing 87 3′UTRs was screened for targeting
by let-7c and miR-10b driven by the PGK promoter.
Experiments were performed with four replicates. Results
were analyzed as above.
MiRNA target literature review
The genes with an RI score <0.8 and P-value <0.05 were
analyzed in a literature search for potential contributions
to tumorigenesis. In the case of a gene having roles in tu-
mors of different origins, emphasis was placed on tumors
originating in breast tissues due to the relevance of let-7c
andmiR-10b to breast cancer progression. Criteria for plac-
ing each gene into a category as either a positive or negative
driver of tumorigenesis included evidence of overexpression
or downregulation, if its role was classified in at least two
publications, and was associated with a defined mechanism
of action. Cases where a gene has opposing roles in distinct
tissues of origin are noted with dual color annotation. Ref-
erences used in this analysis are provided in Supplementary
Table S3.
MiRNA target alignment
The 3′UTRs of top putative hits were analyzed for poten-
tial miRNA target sites using ClustalW (48). To identify
both canonical and likely non-canonical targets, individual
alignments were attempted for nucleotides 2–7, 1–9, 10–22,
and the entirety of the miRNA, against each 3′UTR. The
gap open and gap extension parameters were adjusted be-
tween 10–25 and 0.5–5, respectively, to obtain the best align-
ment in terms of seed binding and 3′ compensatory com-
plementarity. To create the miRNA binding footprint we
used the WebLogo software (49). Gaps in the binding foot-
print corresponding to loops in the mRNA were removed
leaving only the nucleotides that interact with the miRNA.
G:U wobbles were accounted for by first running the soft-
ware with all normal sequences. Second, we temporarily re-
placed all U’s in mRNA sequence with C if the interacting
miRNA nucleotide corresponded with a G and replaced all
G’s with A if the corresponding miRNA nucleotide was a
U. Third, we reran the software, measuring the height of the
combined wobble peaks, and fourth, corrected the original
WebLogo with the heights corresponding to the number of
bits expected if G:U wobbles are accounted for.
Comparison with AGO-HITS-CLIP CLASH data set from
Helwak et al. (2013)
The complete Supplementary data set from (50) was
downloaded from www.cell.com/cell/fulltext/S0092-
8674(13)00439-X. Chimeric reads from all let-7 and
miR-10 family members were searched for genes that were
also present in the 3′LIFE library. Genes whose reads
mapped to regions other than the 3′UTR were binned
separately. Genes with chimeric reads in the 3′UTR were
compared against the scores from the 3′LIFE assay.
Analysis of 3′UTR conservation using PhyloP
For each hit in the 3′LIFE assay that contained a canonical
seed, defined as perfect complementarity with noG:Uwob-
bles in nucleotides 2–7 of the miRNA, conservation scores
were identified using the 100 vertebrates Basewise Conser-
vation by PhyloP track (51) in the UCSC genome browser.
For each gene conservation scores for three loci were ob-
tained: the six nucleotide seed, 200 nucleotides flanking the
seed (score includes seed site), and up to 200 nucleotides
of the terminal exon. The conservation score for each nu-
cleotide in these loci were averaged, and thismean conserva-
tion score for each locus was plotted as a schematic against
a hypothetical gene model.
RESULTS
MiRNA target predictions have high false-negative rates
Several algorithms have been developed to predict
miRNA/mRNA interactions in 3′UTRs corresponding to
each gene in the genome (7). Predictions for miRNA targets
are generally based on the characteristics of previously
validated miRNA target elements and utilize additional
parameters, such as site conservation, to refine putative
target lists. These algorithms generate hundreds to thou-
sands of predicted interactions for each miRNA, and thus
can be used to analyze miRNA targets on a systems level.
However, several groups have reported high false-positive
(12,13) and false-negative rates (9,10). We measured the
efficacy of three widely utilized algorithms, TargetScan
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(5), Diana-microT (42) and PicTar (8) to identify the most
predictive algorithm to compare against results from the
3′LIFE assay. We selected five miRNAs based on their
significant presence in the literature and relevance to cancer
and compared the predicted targets with experimentally
validated targets from the literature (Supplementary Figure
S1A–C). Despite the wide body of literature on these miR-
NAs (thousands in PubMed), there are only 64 validated
targets, representing ∼2% of all bioinformatic predictions.
TargetScan correctly predicted 66% of experimentally
validated targets with the conservation filter enabled, while
Diana-microT and PicTar predicted 53% and 47% of val-
idated targets, respectively (Supplementary Figure S1D).
However, TargetScan predicted 3236 targets, compared
to 2001 by PicTar, which may account for differences in
false-negative rates. We compared all hits from the 3′LIFE
assay against predictions from TargetScan because it
contained the lowest false-negative rate.
3′LIFE is a scalable method to rapidly detect miRNA targets
in high-throughput
Luciferase-based assays are widely used to directly de-
tect miRNA targeting due to their high sensitivity. Com-
mercial high-throughput luciferase reagents are available,
but are cost prohibitive for large-scale approaches. To
overcome these limitations, we have developed a cost-
effective high-throughput assay that systematically screens
miRNA/mRNA interactions in an unbiased and standard-
ized fashion. 3′LIFE is an adaptation of the dual luciferase
reporter assay performed in high-throughput (Figure 1).
The dual luciferase assay relies on the fusion of a test 3′UTR
to a luminescent reporter gene. Targeting and translational
repression of the test 3′UTR by a probe miRNA is identi-
fied by a decrease in the luciferase::3′UTR signal (firefly lu-
ciferase) relative to a second normalization signal (Renilla
luciferase) (Figure 1A, red spots). To account for endoge-
nous miRNAs that may target the luciferase reporter, we in-
clude a no miRNA negative control, which provides a base-
line from which to detect targeting by the exogenous test
miRNAs. 3′LIFE is designed to rapidly identify functional
targets of a given miRNA in a panel of hundreds of test
3′UTRs in co-transfection experiments.
3′LIFE uses two specially designed vectors to express
the test 3′UTRs (pLIFE-3′UTR) and the miRNA (pLIFE-
miRNA) (Figure 1B). In the pLIFE-3′UTR vector, the two
luciferase genes were cloned into the same plasmid to pre-
vent fluctuations in their molar ratios across separate trans-
fections. We have also included a Gateway-compatible re-
combination cassette (GW) cloned downstream of the fire-
fly luciferase gene to efficiently shuttle test 3′UTRs into the
pLIFE-3′UTR vector (Figure 1B (top) and Supplementary
Figure S2A). In the pLIFE-miRNA vector, the miRNA is
cloned within an intron in the 3′UTR of the red fluorescent
protein (45) (Figure 1B (bottom) and Supplementary Fig-
ures S2B and S3), dually functioning as a marker for trans-
fection efficiency and miRNA expression (Supplementary
Figure S3B).
To test the processing and functional activity of the
miRNA expression vectors, we introduced perfect tar-
get sites for each miRNA into the SV40 3′UTR and
co-transfected the pLIFE-SV40 vectors with a negative
miRNA control, let-7c or miR-10b. Each miRNA strongly
repressed only the 3′UTRcontaining its target site, confirm-
ing the processing of the miRNA and demonstrating the
specificity of the targeting (Figure 1C, panels 4–9).
Overexpression of exogenous miRNAs may cause non-
specific or dosage-dependent effects. To test this hypothe-
sis, we replaced the CMV promoter present in the pLIFE-
miRNA vector with the weaker PGK promoter (pLIFE-
PGK). In HEK293T cells, the CMV promoter was pre-
viously reported to be approximately five times stronger
than PGK (52), a result echoed by our own analysis of flu-
orescence expression (Supplementary Figure S4). Impor-
tantly, the PGK promoter is also used to drive expres-
sion of the firefly luciferase::3′UTR reporter, thus expres-
sion levels of these two genes should be equivalent in the
pmiRNA-PGK experiment. Repeating the SV40 targeting
experiments with the pLIFE-PGK miRNA expression vec-
tor yielded decreased translational repression (Figure 1C,
panels 10–15), although not to the extent expected by de-
creasing expression levels 80% (Figure 1C, compare panel
5 with panel 11, and panel 9 with panel 15). While it is
possible that the translation of the RFP may be effected
by unknown 5’UTR elements provided by the CMV and
PGK promoters, the strong functional differences between
the same miRNA driven by these two promoters suggests
that there are transcriptional differences(Figure 1C, Supple-
mentary Figure 3).
The feasibility of high-throughput dual luciferase assays
is limited by high costs associated with transfection and lu-
ciferase assay reagents, and the lack of a publicly available
human 3′UTR library. Furthermore, genome-wide screens
for miRNA targets are challenged by the need for appropri-
ate high-throughput technologies and pipelines. 3′LIFE as-
say utilizes low-cost non-proprietary transfection and dual-
luciferase reagents (23) (Supplementary Figure S5). We
have designed each step of the 3′UTR cloning pipeline and
the 3′LIFE assay to be highly automated (Supplementary
Figure S6). PCR, cloning, plasmid DNA preparation, cell
culture, transfection and luciferase assays are performed
in 96-well format using multi-channel micropipettes, dedi-
cated liquid handling robots and other high-throughput in-
strumentation.
To test the 3′LIFE assay, we chose a pilot library of 384
human 3′UTRs containing experimentally validated tar-
gets (n = 10) and bioinformatically predicted targets (n =
47) of let-7c and miR-10b, as well as genes that play regu-
latory roles in tumorigenesis (Figure 1D and Supplemen-
tary Table S2). This human 3′UTR clone collection is pub-
lically available through the DNASU plasmid repository
(http://dnasu.org) (44). More clones are periodically added
to the library, with the goal of covering the entire human
3′UTRome.
Here, we screened 275 of these 3′UTRs for potential
targeting by each miRNA, performing four replicates of
each experiment using the pLIFE-miRNA vector (totaling
∼3500 transfection reactions and luciferase assays). To de-
tect miRNA targeting, each 3′UTRwas co-transfected with
themiRNA, and the luciferase ratio was compared to a neg-
ative control. Putative hits are defined as those that have
an RI below the mean standard error of the assay (0.15 for
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Figure 1. The 3′LIFE Assay. (A) Schematic of the 3′LIFE assay. A reporter library of luciferase::3′UTR fusion genes is cotransfected in HEK293T cells
with miRNAs of interest and a negative control in 96-well format. Following transfection cell lysate is used in a dual luciferase assay, and target genes are
identified by a significant repression of the luciferase gene compared to the negative control (B) 3′LIFE Vector Design. (Top) Gateway compatible dual
luciferase expression vector. The 3′UTRof interest is cloned downstream of firefly luciferase usingGateway cloning. Both luciferase genes are located on the
same plasmid to prevent fluctuations in the luciferase ratio across experiments. (Bottom) Gateway compatible miRNA expression plasmid. The miRNA
of interest is cloned within an intron in the 3′UTR of RFP using Gateway cloning. This approach functions dually as a visual marker for transfection
efficiency and miRNA expression. (C) Positive controls for let-7c and miR-10b. The SV40 3′UTR containing a scrambled miR-10b target site (blank) or
let-7c andmiR-10b targets were cloned into the pLIFE-3′UTRand tested in quadruplicate using a dual luciferase assay. Results are normalized to the Blank
condition of each 3′UTR. Y-axis measures the percentage of repression compared to the Blank condition. Error bars are standard error unless otherwise
noted. * denotes statistical significance (Student’s t-test, *P < 0.05, **P < 0.01 and ***P < 0.001). (D) Gel electrophoresis of 384 3′UTRs amplified from
human genomic DNA using touchdown PCR for use in the 3′LIFE assay.
let-7c and 0.16 for miR-10b). These putative hits were en-
riched with bioinformatically predicted targets and previ-
ously validated targets for both let-7c (E2F5, RTCA, PBX3,
TRIM71) and miR-10b (SDC1, NCOR2, HOXD10) (Fig-
ure 2A, arrows). Surprisingly, we detected repression in only
62% of genes predicted by TargetScan.
To further refine our putative hits to only high-confidence
targets, we set a cutoff for genes with an RI <0.80 and
P-value <0.05. Using this criterion we obtained 37 high-
confidence hits for let-7c and 26 formiR-10b (Figure 2B). To
identify putative miRNA target sites within these top hits,
we scanned each 3′UTR for elements highly complemen-
tary to the miRNA (Supplementary Table S1). While 63%
of these 3′UTRs contained perfect seed elements, only 32%
were predicted by TargetScan, presumably because they
contain either poorly conserved canonical seeds or non-
canonical target sites.
Strong miRNA and weak miRNA overexpression yield com-
parable results
We were then interested in studying the extent of non-
specific or dosage-dependent targeting caused by miRNA
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Figure 2. Results of the 3′LIFE pilot study. (A) Two hundred and seventy five 3′UTRswere probed for targeting by let-7c (left) ormiR-10b (right). RI values
(see the Materials and Methods section) represent the average of four replicates. 3′UTRs were considered putative hits if the RI falls below the standard
error for each miRNA (dashed line). Bioinformatically predicted genes are extracted and ranked (right of each panel), demonstrating an enrichment for
predicted targets among putative hits. Previously validated targets are marked with black arrows. (B) Top hits obtained are defined as those with RI <
0.80 and P < 0.05. let-7c had 37 and miR-10b had 26 top hits, the majority of which contain canonical target sites. (C) List of top hits in 3′LIFE assay.
Putative seed target site is listed as defined in (5). Each gene was identified as having a positive role (green), negative role, conflicting roles (red/green) or
no identifiable or established role in tumorigenesis based on a manual literature review (see the Materials and Methods section and Supplementary Table
S3).
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overexpression. We rescreened one plate of 3′UTRs (n =
87) using the pLIFE-PGK miRNA expression vector, re-
peating the assay in quadruplicate (a total of 1152 transfec-
tion reactions and luciferase assays) (Supplementary Figure
S7A). The RI of each gene tested against varying extents of
miRNA overexpression yielded largely comparable results,
with the majority of genes having some degree of repression
in both, or neither (Supplementary Figure S7A). Among
the top hits obtained with pLIFE-miRNA vectors, 77% of
targets were also repressed with the pLIFE-PGK vectors,
albeit generally to a lesser degree (Supplementary Figure
S7B and C). We obtained three genes not repressed with the
pLIFE-miRNA screen that show significant repression (RI
< 0.80, P < 0.05) by miR-10b in the pLIFE-PGK experi-
ment (AATK, HOXA1, KRT1). HOXA1 and KRT1 con-
tain perfect seed matches for miR-10b, while AATK con-
tains a highly complementary non-canonical target (Sup-
plementary Figure S7D). In conclusion, these data suggest
that while there may be a dosage effect for a small portion
of miRNA targets, the majority of targets show consistent
repression regardless of the degree of miRNA overexpres-
sion.
Putative miRNA target genes have functions consistent with
known role of each miRNA in cancer
We next sought to identify potential correlations between
the functional role of each miRNA in tumorigenesis and
the novel targets identified by our pilot 3′LIFE assay. We
performed a literature review for the top gene targets to de-
termine if our ‘bona fide’ targets were previously recognized
to have positive or negative contributions to tumorigene-
sis (Figure 2C and Supplementary Table S3). let-7c targets
identified by the 3′LIFE assay are generally overexpressed
in tumors and have positive roles in tumorigenesis, which
is consistent with the tumor suppressor function of let-7c.
Conversely, miR-10b target genes are typically downregu-
lated in late-stage tumors and inhibit cancer progression
and metastasis, which is also consistent with miR-10b as an
indicator of late-stage, aggressive tumors (Figure 2C).
Each miRNA exhibits a unique binding footprint
Analysis for enriched nucleotides in these putative miRNA
target sites revealed that the seed was the least variant re-
gion within the target element of both miRNAs (Figure
3A). The 3′end of the miRNA also showed consistent inter-
action with themRNA compared to the central nucleotides.
let-7c also possesses a more even distribution of interact-
ing nucleotides compared to miR-10b, which has two dis-
tinct regions at the terminal ends. The mean bit score gives
a measure of the extent to which each nucleotide interacts
with the target mRNA, and in let-7c it is slightly higher
than in miR-10b (1.03 compared to 0.86), suggesting that
let-7c interacts with more nucleotides in each target mRNA
than miR-10b. As G:U base pairing expands the flexibility
of these nucleotides to interact with more than one base,
we compared the bit score of G/U and A/C nucleotides.
G/U’s outside the seed region were twice as likely to inter-
act with corresponding mRNA nucleotides than A/C (0.85
compared to 0.43), which is expected given that the num-
ber of nucleotides that G/U can pair with is double that
of A/C. The five 3′-most nucleotides of both miRNAs are
G/U’s, whichmay account for the targeting peaks in this re-
gion. Of note is the high percentage of G/U nucleotides in
let-7c (82%) compared to miR-10b (52%), which may con-
tribute to the overall higher bit score, the increased number
of bioinformatically predicted targets (Supplementary Fig-
ure S1A) and the larger number miRNA targets detected by
the 3′LIFE screen (Figure 2B) for let-7c compared to miR-
10b.
Seed elements are conserved compared to surrounding 3′UTR
sequence
Thirty percent of 3′UTRs in the target library contain
canonical seed elements. Within this group, more than half
were among 3′LIFE top hits, suggesting that 3′LIFE hits
are enriched with genes containing canonical seeds. Among
the 3′LIFE top hits, 73% contain a canonical seed (46 out
of 63), yet only 32% were predicted bioinformatically (20
out of 63). We reasoned that most of these canonical tar-
gets escaped prediction because the seed element is poorly
conserved. To address this discrepancy we measured the se-
quence conservation among vertebrates for both predicted
and unpredicted canonical seed elements within the 3′LIFE
top hits. We then compared the results to the conservation
levels in the open reading frames and in the 3′UTRs of the
same genes (Figure 3B). Not surprisingly, the seed region
in predicted targets was four times more conserved than in
non-predicted targets. However, in both the terminal exon
and the 3′UTR of non-predicted targets we observed far
less conservation compared to the same regions in predicted
targets. This suggests that when comparing conservation of
genes as a whole, the degree of conservation of unpredicted
genesmay automatically exclude any canonical targets from
prediction by algorithms using conservation criteria. Fur-
thermore, the seed region in unpredicted targets is twice
as conserved as the surrounding 3′UTR, a jump similar in
magnitude to that of predicted seed targets. This suggests
that despite the relatively poor conservation of unpredicted
targets, these elements are possibly functional as there is in-
deed some selective pressure to maintain them. Taken to-
gether, these results suggest that the lack of conservation in
the seed region is not solely responsible for the failure of
TargetScan to predict the miRNA targets that are detected
by the 3′LIFE assay, but that the lack of conservation in the
3′UTR itself plays a role in increasing false-negative rates of
prediction softwares.
To further validate non-canonical targets sites among
the top hits of 3′LIFE, we selected two genes, RhoB and
HOXD11, and deleted the putative target sites for let-7c and
miR-10b, respectively (Figure 3C). Deleting these elements
completely rescued each 3′UTR from repression by their re-
spective miRNAs, demonstrating that the 3′LIFE assay is
capable of identifying non-canonical miRNA/mRNA in-
teractions (Figure 3C).
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Figure 3. Characterization of target sites within top 3′LIFE hits. (A) Target signature motif of putative miRNA target sites within top hits identified using
ClustalW alignments. The black box represents themiRNA seed region. Black horizontal lines indicate nucleotides within themRNAwith a bit-score>0.8.
(B) Mean conservation scores of the nucleotides in terminal exon, miRNA target site, and flanking 3’UTR of genes possessing perfect seed matches. Scores
are plotted log(2) scale along a hypothetical gene model. 3’UTRs are separated based on the TargetScan prediction status of each gene. Conservation score
is obtained using the PhyloP vertebrate conservation track on UCSC genome browser. (C) Deletion analysis of two top non-canonical miRNA target sites
identified in 3′LIFE assay. Map showing the relation of the miRNA target site within the 3′UTR relative to polyadenylation sequences (AAUAAA). Red
boxes indicate canonical seed nucleotides. Each 3′UTR containing either the wild-type or deleted miRNA target site is cotransfected with Blank miRNA
control, let-7c or miR-10b.
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DISCUSSION
3′LIFE is a highly sensitive method to detect miRNA targets
in high-throughput
In this study we present a novel, scalable and sensitive
method to identify miRNA targets in high-throughput,
which addresses a critical need in miRNA biology. Cur-
rently, bioinformatic and RISC-IP approaches are the only
tools to investigate miRNA targets in a high-throughput
manner.
Bioinformatic approaches utilize a suite of parameters
to predict highly likely targets, such as target composition
(i.e. miRNA seed regions), site conservation and thermo-
dynamic stability, and benefit from the ability to identify
sites throughout the entire genome. While these algorithms
are indispensable tools to identify candidate genes for ex-
perimental validation, their high false-positive and false-
negative rates suggest that the parameters upon which these
algorithms are built do not yet account for all the mecha-
nisms miRNAs use to recognize target sites. Genome wide
bioinformatic predictions are only useful in the absence of
experimental tools that deliver results at a comparable scale.
AGO-HITS-CLIP provides a high-throughput experimen-
tal approach to identify miRNA targets in a specific con-
text, i.e. cell line or tissue. When we compare our results
with data obtained from similar approaches, we note that
IP-based assays limit the findings to the set of abundantly
expressed transcripts and that occupancy of anmiRNA at a
specific target site may not necessarily result in translational
repression (Supplementary Figure S8). Dual luciferase re-
porter assays are rapid, sensitive and quantitative and mea-
sure the functional output of miRNA interactions at the
protein level. Despite the widespread use of dual luciferase
assays to validate miRNA targets, the notable lack of use
in initial high-throughput screens speaks to the substantial
technical and methodological barriers to such applications.
These barriers include the lack of a high-quality publicly
available 3′UTR reporter library, the high costs associated
with transfection and luciferase assay reagents and the ab-
sence of standardized high throughput protocols and data
analysis pipelines.
The 3′LIFE assay overcomes the above challenges by (i)
measuring the effect of miRNA targeting at the protein
level, (ii) utilizing a reporter assay that is quantitative and
highly sensitive to subtle fluctuations in protein concentra-
tion, (iii) does not rely on prior assumptions about miRNA
targets to generate candidate gene libraries and (iv) by us-
ing a high-throughput screening approach it becomes pos-
sible to detect subtle repression in a large number of genes
due to the large number of negative interactions built into
the assay. This last point is of critical importance, in that
evidence suggests that miRNAs exert significant influence
on the transcriptome not by strongly repressing individual
genes, but by subtly repressing many targets (see below).
In this ‘proof-of-principle’ screen we tested 275 3′UTRs
for targeting by let-7c and miR-10b and observed repres-
sion in a large number of novel putative targets, eight of 10
previously validated targets, and 62% of the bioinformati-
cally predicted genes included in this 3′UTR library (Fig-
ure 2A). Among the top hits in the 3′LIFE assay were genes
targeted by non-canonical target sites (27%) (Figure 2C),
poorly conserved canonical seeds (Figure 3B) and genes fre-
quently utilizing G:U wobble pairing (Figure 3A and Sup-
plementary Table S1). These degenerate targeting principles
expand the repertoire of potential miRNA target sites, con-
tribute to the observation that only 32% of the top 3′LIFE
hits were bioinformatically predicted and support the use
of unbiased high-throughput experimental approaches to
identify miRNA targets.
Surprisingly, 20% of previously validated targets and 38%
of bioinformatically predicted targets showed no detectable
degree of repression. Previous groups have reported sim-
ilar false-positive rates for prediction algorithms (12,13),
suggesting that algorithm error rates may account for the
lack of targeting in this screen. However, false negatives
could also be explained by several biological factors. First,
sequence elements flanking putative canonical target sites
that possess high degrees of secondary structure may have
a critical impact on target recognition by restricting the
access of the miRNA silencing machinery to the target
site (53,54). Second, cooperative repression by multiple
miRNA target sites (55) or interactions with trans-acting
factors such as RNA-binding proteins (56) can contribute
to miRNA target recognition that requires multiple trans-
acting factors, resulting in targeting only in specific con-
texts. Third, recent studies indicate that a large portion of
eukaryoticmRNAs are reversiblymethylated, preferentially
within non-coding regulatory regions, and potentially con-
tributing to the evasion of miRNA targeting (57). Lastly,
alternative polyadenylation may increase the false-negative
rate in the 3′LIFE assay. Fifty percent of human genes con-
tain multiple polyadenylation signals within 3′UTRs that
signal transcription termination, cleavage and polyadeny-
lation (58,59). Rapidly proliferating and tumor cells were
shown to possess, on average, shorter 3′UTR isoforms, a
mechanism resulting in the evasion of miRNA regulation
(60–62). Alternative polyadenylation may also result in the
exclusion of miRNA target sites in a context-dependent
manner, by producing short 3′UTR isoforms only in certain
cell lines or tissues. Thus, context-specific targeting mecha-
nisms, including interactions with trans-acting factors and
alternative polyadenylation, may contribute to false nega-
tives in the 3′LIFE assay.
Conversely, overexpression of regulatory factors, such as
miRNAs,may yield false-positive results due to non-specific
repression of the reporter gene or supraphysiological ex-
pression levels driving specific, yet biologically irrelevant re-
pression. The first scenario results from cascades of regu-
latory interactions that may alter the expression levels of
other regulatory genes, which in turn target the reporter.
Such false positives are a major caveat to overexpression
experiments and, in general, are difficult to detect. Non-
specific effects are particularly pronounced in experiments
utilizing RNA-Seq or proteomics approaches to identify
miRNA targets among endogenous genes, in that the re-
pression can occur both pre- and post-transcriptionally, and
be driven by sequence elements at any region of the mRNA.
Because 3′LIFE utilizes only the 3′UTR in the reporter
genes, non-specific effects are minimized to downstream
factors that regulate elements within the 3′UTR, such as
miRNAs and RNA-binding proteins. 3′LIFE minimizes
 at A
rizona State U
niversity W
est 2 on M
arch 25, 2015
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
12 Nucleic Acids Research, 2014
these effects by performing the luciferase assay shortly (48–
72 h) following transfection, reducing the time in which
any changes may occur. Any non-specific targeting effects
would have to occur following a chain of events, includ-
ing transcription and processing of the exogenous miRNA,
miRNA targeting and any subsequent downstream events
(i.e. transcription and translation/miRNA processing). Fi-
nally, these changes would need to result in the downregu-
lation of the reporter 3′UTR to an extent comparable with
the strongly expressed exogenous miRNA. Several pieces
of evidence suggest that the top hits detected by 3′LIFE
suffer little from such false positives. First, 73% of the top
hits detected by 3′LIFE contain canonical miRNA target
sites, a significant enrichment compared to the remainder
of the library (∼17%) (Figure 2B). Second, among the non-
canonical putative target genes, we have experimentally vali-
dated direct targeting of two genes by deletion analysis (Fig-
ure 3C), suggesting that 3′LIFE can identify direct repres-
sion of genes targeted via non-canonical sites. Lastly, we ob-
serve relative conservation of the canonical seed elements,
both predicted and unpredicted, within our top hits, sug-
gesting that these are evolutionarily maintained functional
target sites (Figure 3B). While false positives due to indi-
rect regulatory interactions are certainly plausible events,
the above evidence suggests that the top hits from 3′LIFE
are ‘bona fide’ direct miRNA targets.
The second scenario yielding false positives, where
miRNA overexpression results in specific and direct reg-
ulatory interactions that only occur at supraphysiological
levels, is a primary concern in generalizing results from ex-
periments that rely on miRNA overexpression. The relative
abundance between miRNAs and their target mRNA can
influence the degree of repression, as well as the phenotypic
consequences of miRNA targeting, thus experimental ap-
proaches that mimic physiological miRNA/mRNA levels
may yield less such false positives. To address this concern
we screened a portion of the 3′UTR library with miRNAs
driven by a relatively weak promoter that drives both the lu-
ciferase reporter and miRNA genes (Supplementary Figure
S7). The weak promoter repressed 10 of the 13 top hits iden-
tified by the strong promoter, albeit to a lesser extent. Inter-
estingly, there were also three genes that were significantly
repressed by the weak promoter and not the strong pro-
moter (Supplementary Figure S7D). Of these three genes,
two contain perfect seed matches, and the third a perfect
seed shifted one nucleotide outside of the canonical posi-
tion.
These data suggest that while the majority of 3′UTRs are
consistently repressed regardless of the degree of overex-
pression in the 3′LIFE assay, miRNA overexpression may
yield both false-positive and false-negative results. In con-
clusion, the context, i.e. cell lines, used to identify miRNA
targets is typically dependent on the biological questions be-
ing asked, therefore caution must be taken when generaliz-
ing results across cellular contexts.
MiRNAs target multiple genes within biological pathways
The effect of miRNA targeting on protein production is
generally understood to result in modest translational re-
pression (7,13), and can be influenced by several factors.
These factors include the number of target sites in the
mRNA, target site characteristics, with interactions guided
by canonical seeds and high degrees of complementarity in
the 3′end of the miRNA resulting in stronger repression,
and position in the 3′UTR relative to the polyadenylation
site, with more distal target sites generally showing stronger
repression (7). These observations led to the hypothesis that
a primary effect of gene regulation via miRNAs is not to
serve as a switch, turning protein production on or off, but
instead functions as a mechanism to fine-tune protein out-
put, protect against aberrant levels of gene expression and
provide robustness to cell-specific programs (63,64). Thus,
the discrepancy between the modest impact an miRNA has
on any single message and the powerful role specific miR-
NAs have in diverse biological processes suggests that miR-
NAs must target multiple genes at various nodes in these
networks in order to obtain more vigorous regulation. For
the emergence of such a multi-faceted mechanism, miR-
NAs and/or their targets would require a high degree of
evolvability. In support of this notion is the observation
that in metazoan genomes miRNAs have undergone three
major expansions in recent evolutionary history, with the
number of miRNAs correlating with organismal complex-
ity (65). These expansions are driven primarily by the du-
plication and divergence of miRNAs, resulting in miRNA
families, members of which are distinguished by only a few
nucleotides in the mature miRNA. Furthermore, the small
size and degenerate nature of miRNA target elements, com-
bined with the relatively rapid evolutionary flexibility of
3′UTRs (66), suggests that miRNAs are capable of readily
evolving novel targets (67). Consistent with these hypothe-
ses, the 3′LIFE assay identified an enrichment of specific
pathways among the top hits targeted by each miRNA, in-
cluding central members, upstream regulators, and down-
stream effectors of RAS signaling for let-7c, and the retinoic
acid (RA) signaling pathway for miR-10b.
let-7c targets multiple genes within the RAS signaling path-
way
Loss of let-7 family members correlates with poor survival
rates inmany cancers (26–29), in part by inhibiting the RAS
signaling pathway by targeting several elements within the
3′UTRs of KRAS and NRAS (30,33,68). Consistent with
the hypothesis that miRNAs function by targeting multiple
members of the same pathway, the top hits for let-7c iden-
tified by 3′LIFE were enriched for multiple genes within
the RAS signaling pathway. Among these genes were two
small GTPases within the RAS superfamily (RhoB, RhoV).
RhoB has conflicting reports of its role in tumorigenesis de-
pendent on tumor type (69–71). let-7c targets RhoB at a sin-
gle non-canonical target site (Figure 3C). Recent evidence
also suggests that RhoV overexpression may contribute to
tumorigenesis (72). In addition to these central signaling
components, 3′LIFE also identified several downstream ef-
fectors of the RAS signal (ID1, HSF1, CRK, DNMT1,
ARID3A, EZH2). Inhibitor of differentiation 1 (ID1) reg-
ulates the activity of several transcription factors, is posi-
tively correlated with tumor progression, is transcription-
ally activated in aKRAS-dependent manner in culture (73),
is a downstream effector or RAS signaling in fibrosarco-
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mas (74) and cooperates with RAS in metastatic breast tu-
mors in vivo (75). Heat shock factor 1 (HSF1) is a tran-
scription factor and downstream effector of RAS signal-
ing, and is required for malignant transformation induced
by oncogenic RAS (76–80). V-CRK avian sarcoma virus
oncogene (CRK) is an adaptor protein that binds to several
tyrosine-phosphorylated proteins, and by interacting with
multiple signaling pathways suppresses cell adhesion and
contributes to transformation in the presence of oncogenic
RAS (81,82). AT-rich interacting domain 3A (ARID3A) is
a transcription factor that has been shown to rescue RAS-
induced senescence, promoting cell survival and immor-
talization (83,84). DNA methyltransferase 1 (DNMT1) is
overexpressed in a variety of tumors and is required for
RAS-dependent epigenetic silencing of several tumor sup-
pressors (85–87). Enhancer of zeste homolog 2 (EZH2) is a
member of the polycomb family of transcriptional repres-
sor proteins, its expression is an initiating event of a va-
riety of tumors induced by oncogenic RAS and results in
a wide range of downstream effects including transforma-
tion and metastasis (88–90). Among these eight let-7c tar-
get genes, ARID3A and EZH2 are the only bioinformati-
cally predicted targets (Figure 2A), while CRK, ARID3A,
EZH2 and HSF1 contain canonical seed elements within
their 3′UTRs (Figure 2C).
miR-10b targets are enriched for multiple genes within the
RA signaling pathway
Recent studies link the miR-10 family to the RA signaling
pathway, yet report conflicting roles of these miRNAs in tu-
mor progression. In neuroblastoma miR-10a and miR-10b
positively regulate the activity of RA signaling and promote
differentiation (36), while the ability ofmiR-10a to promote
metastasis in pancreatic ductal adenocarcinoma is inhibited
by RA treatment (91). While context is critical in relation
to the response of a cell to RA signaling, the overexpres-
sion of miR-10 in various late-stage tumors and its induc-
tion of invasion and migration is well documented (92,93).
In line with these observations, 3′LIFE confirmed three pre-
viously validated targets (SDC1, NCOR2 and HOXD10)
and identified seven novel targets of miR-10b with vari-
ous roles in the RA signaling pathway. These include up-
stream regulatory effectors of the RA response (RARG,
NCOA6, NCOR2, ASCL2), as well as downstream tran-
scriptional targets (HOXD1, HOXD10, HOXD11, SDC1,
STAT6, MYF5).
The effectors of the RA response, the RA receptors
(RARs), are ligand-dependent transcription factors that are
central regulators of a wide range of biological processes.
RA is a potent inhibitor of tumorigenesis by activating
networks of genes via RARs (94) and generally promotes
differentiation in various contexts (95). The RAR gamma
(RARG) was a top hit in 3′LIFE and has been linked to
conflicting aspects of tumorigenesis. RARG promotes dif-
ferentiation and cell cycle arrest in keratinocytes (96) and
neuroblastoma (97), and differentiation, apoptosis (98) and
inhibition of invasiveness in melanomas (99). Conversely,
RARG has been shown to have oncogenic properties in car-
cinomas by activating the Akt/NF-k and Wnt/-catenin
pathways (100,101). NCOR2/SMRT and NCOA6/ASC2
are both nuclear receptor cofactors that physically inter-
act with the RARs. NCOR2/SMRT has conflicting reports
of its contribution to tumorigenesis dependent on tumor
type, but is responsible for integrating estrogen and RAR
signals by recruiting chromatin remodeling complexes that
repress target gene transcription in the absence of the lig-
and hormone (102). In contrast, NCOA6/ASC2 is a nu-
clear receptor coactivator that outcompetes nuclear core-
pressors in binding nuclear receptors in the presence of RA,
resulting in transcriptional activation of RAR target genes.
NCOA6/ASC2 is also frequently upregulated in various tu-
mors (103,104). ASCL2 is a transcription factor that is crit-
ical in the maintenance of adult intestinal stem cells and
interacts with RARs via direct interaction with NCOA6
(105).
Interestingly, we also identified several downstream tran-
scriptional targets of RA signaling, including HOXD1,
HOXD10 and HOXD11, whose genomic locus also con-
tains the miR-10b gene itself. The entire HOXD gene clus-
ter responds to RA treatment by sequentially activating
the transcription of the HOXD genes, generally promot-
ing the differentiation of a variety of tissues (106,107).
HOXD10 is the only bioinformatically predicted member
of the HOXD cluster and was the first experimentally val-
idated target of miR-10b, yet we identify three members
of this cluster as targets of miR-10b and demonstrate that
miR-10b targets HOXD11 by a single non-canonical tar-
get site (Figure 3C). SDC1/CD138 is a cell surface pro-
teoglycan that plays a role in adhesion to the extracellu-
lar matrix (108), is frequently downregulated in multiple
myelomas (109) and other cancers and is upregulated in re-
sponse to RA treatment (110,111). STAT6 is a transcrip-
tion factor that is a key effector of IL4-mediated signaling
and promotes growth inhibition, apoptosis and differenti-
ation in breast tumors (112,113). STAT6 is also transcrip-
tionally activated in response to RA treatment in T-helper
cells (113) and requires interaction with a nuclear receptor
coactivator (NCOA1) to enact the IL4 response in hepato-
cytes (114). Lastly, MYF5, a transcription factor central to
skeletal muscle differentiation, is also activated in response
to RA in the developing limb bud (115). Among these 10
targets ofmiR-10b, NCOR2,NCOA6,HOXD10 and SDC1
are the only bioinformatically predicted targets (Figure 2A),
and RARG, NCOR2, NCOA6, HOXD1, HOXD10, SDC1
and STAT6 contain canonical seed elements within their
3′UTRs (Figure 2C).
The identification of target genes associated with RAS
signaling (let-7c) and RA signaling (miR-10b) by 3′LIFE
is consistent with the known roles of these miRNAs as ei-
ther negative or positive regulators of tumorigenesis, respec-
tively, and potentially broadens the scope by which they tar-
get these pathways. Furthermore, the novel, non-canonical
and unpredicted targets within these pathways suggest that
unbiased, high-throughput approaches to identify miRNA
targets is a productive strategy to identify regulatory net-
works targeted by miRNAs.
In conclusion, our study suggests that 3′LIFE is a pow-
erful method to identify novel and non-canonical miRNA
targets, and to identify mechanisms by which miRNAs con-
tribute to biological processes. 3′LIFE conveys several ad-
vantages over current methods. First, 3′LIFE is a compre-
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hensive screen because it utilizes all functional elements
present in each 3′UTR that are targeted by the query
miRNA. Second, 3′LIFE is unbiased, since it probes one
interaction at a time and does not rely on prior assumptions
about target genes. Third, the detection of an miRNA tar-
get requires direct translational inhibition of the 3′UTR in
the presence of the miRNA, providing a functional mea-
sure of targeting. Fourth, the sensitivity of the assay is
greatly improved by its high-throughput nature, revealing
subtle targeting of multiple genes within regulatory net-
works. Lastly, 3′LIFE is flexible in that it can be adapted
to detect other functional elements in 3′UTRs targeted by
non-coding RNAs and RNA-binding proteins. Although
3′LIFE is a powerful experimental tool to detect miRNA
targets in high-throughput, the complementary wet-lab and
bioinformatic approaches described above are informative
to refine, validate and expand the results obtained by this as-
say.While the biological relevance of miRNA targets identi-
fied by 3′LIFE cannot be assigned, this assay provides rapid
detection and initial validation of direct miRNA/3′UTR
target interaction at a scale not possible with current meth-
ods.
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